
This PhD project aimed to use deep sequencing of single-cell RNAs to identify the unique gene expression profiles and heterogeneities in islet-derived white blood cells during autoimmune type 1 diabetes progression but also from therapeutic responders and non-responders. Moreover, he wanted to correlate these tissue-specific immune signatures with circulating (cell-free plasma) small non-coding RNAs during disease progression and in responders and non-responders pre- and post-therapy to identify potential markers for disease staging, prognosis, and therapy prediction.
The full text can be found via this link.